However, in a larger analysis including 63 colorectal tumours we previously demonstrated that EGFR promoter methylation should not be considered a rare event in colorectal tumours as this biological phenomenon occurred in as many as 39% of all cases analysed (Scartozzi et al, 2009). This evidence concerns the gene EGFR and colorectal neoplasm.